Abbott Laboratories Patent Portfolio Statistics

Abbott Laboratories

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Abbott Laboratories look like?

Total Applications: 4,005
Granted Patents: 2,350
Grant Index 64.54 %
Abandoned/Rejected Applications: 1,291 (35.46%)
In-Process Applications: 363
Average Grant Time: 3.23 Years
Average Office Actions: 1.86

Which Technology Area Abbott Laboratories is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1624 Organic Chemistry 265
1626 Organic Chemistry 242
1625 Organic Chemistry 214
1623 Organic Chemistry 138
1615 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs 92

How many patents are Abbott Laboratories filing every year?

Year Total Applications
2022 0*
2021 14*
2020 45
2019 48
2018 63

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Abbott Laboratories in USPTO?

Publication number: US20220007704A1
Application number: 17/486,328

Disclosed embodiments provide nutritional compositions and methods of enhancing maturation of an infant's brain. The methods include the step of administering to the infant a nutritional composition comprising a protein with a degree of hydrolysis of 10% to 75% in combination with at least one of a monoglyceride, a free fatty acid, a salt of a free fatty acid, a phospholipid, and cholesterol.

Publication date: 2022-01-13
Applicant: Abbott Laboratories
Inventors: Johns Paul

Publication number: US20220011335A1
Application number: 17/479,575

Example apparatus and methods related to automated diagnostic analyzers having rear accessible track systems are described herein. An example apparatus disclosed herein includes an analyzer to perform a diagnostic test. The analyzer has a first side and a second side opposite the first side. The example apparatus includes a loading bay disposed on the first side of the analyzer to receive a first carrier and a pipetting mechanism coupled to the analyzer adjacent the second side. The example apparatus also includes a first carrier shuttle to transport the first carrier from a first location adjacent the loading bay to a second location adjacent the pipetting mechanism and a track disposed adjacent the second side of the analyzer to transfer a second carrier to a third location adjacent the pipetting mechanism.

Publication date: 2022-01-13
Applicant: Abbott Laboratories
Inventors: Hirotoshi Tahara

Publication number: US20210401862A1
Application number: 17/473,298

Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.

Publication date: 2021-12-30
Applicant: Abbott Laboratories
Inventors: Enrique Hernandez Vazquez

How are Abbott Laboratories’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/486,328 Nutritional Compositions Comprising Hydrolyzed Protein And A Modified Fat System And Uses Thereof OPAP Central, Docket
17/479,575 Automated Diagnostic Analyzers Having Rear Accessible Track Systems And Related Methods OPAP Central, Docket
17/473,298 Methods For Modulating Corticosterone Levels In Psychologically Stressed Individuals Docketed New Case – Ready for Examination OPAP Central, Docket
17/375,737 Inductive Heating Systems And Methods Of Controlling The Same To Reduce Biological Carryover Docketed New Case – Ready for Examination OPAP Central, Docket